Atlas Trials

Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma

Clinical trial NCT05717712 · RECRUITING

Trial details

NCT number
NCT05717712
Sponsor
Capital Medical University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Oncolytic VirusDiffuse Intrinsic Pontine GliomaAdverse Drug Event
Start date
2023-01-04
Primary completion
2025-01-04
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.